Gabriel Roybal, PhD

Director Of Cs, Heor Rwe | Clinical Development | Medical Affairs | Market Accesss @ Komodo Health

About Gabriel Roybal, PhD

Gabriel Roybal, PhD, is the Director of CS, HEOR-RWE at Komodo Health, with extensive experience in the life sciences and biopharma industry.

Education and Expertise

Gabriel Roybal, PhD, completed his undergraduate education at the University of Pennsylvania, where he studied Biological Basis of Behavior and Psychology, earning a B.A. He then pursued advanced studies at the University of California, Santa Cruz, focusing on Molecular, Cell, and Developmental Biology, and achieved a Ph.D. He possesses expertise in Clinical Development, Medical Affairs, Market Access, and Health Economics and Outcomes Research (HEOR).

Professional Background

Gabriel Roybal has an extensive professional background in the Life Sciences and Biopharma industry, with over six years of experience. He began his career as a National Human Genome Research Institute Scholar and PhD candidate at UC Santa Cruz from 2005 to 2010. He then served as an NIH IRACDA Scholar in Science Postdoctoral Fellow at UCSF from 2010 to 2014. In various roles at Science Exchange from 2016 to 2020, which included Senior Scientist, Director of Research and Development, and Director of Business Development, he displayed his skills in scientific consulting and business strategies.

Current Role at Komodo Health

Currently, Gabriel Roybal serves as Director of CS, HEOR-RWE | Clinical Development | Medical Affairs | Market Accesss at Komodo Health in the San Francisco Bay Area. In this role, he leads a team of professionals delivering key healthcare data insights to Pharma and Biotech companies globally. His mission is to reduce the burden of disease and improve community health by ensuring diversity in clinical trials and the real-world impact of treatments. He leverages his expertise in HEOR, clinical development, data analysis, and cross-functional collaboration to support customers.

Previous Experience

Prior to his current role, Gabriel Roybal was the Director of Real-world Evidence and Health Economics Outcomes Research at Komodo Health from 2020 to 2022. He also served as VP Business Development and Growth Strategies at TapGenes for 9 months in 2015-2016, and as Founder and Chief Marketing Officer at grouphub.io from 2014 to 2015. His earlier roles include significant positions at Science Exchange, where he was Director of Business Development, Director of Research and Development, and Senior Scientist. This diverse experience underscores his track record in strategic partnerships and scientific consulting.

Volunteerism and Mission

Gabriel Roybal is passionate about volunteerism and advocacy in the HIV space. His mission is to reduce the burden of disease and improve community health. He is dedicated to ensuring diversity in clinical trials and emphasizing the real-world impact of treatments. This commitment highlights his broader commitment to health and wellbeing outside of his professional work.

People similar to Gabriel Roybal, PhD